0.0091
Aditxt Inc (ADTX) 最新ニュース
ORCL Stock Tumbles 10% Despite Earnings Beat, But Wall Street Recommends 'Aggressive' Buying On Selloff - Stocktwits
ADTX Stock Surges 40% Overnight: New 10% Holder Emerges After Aditxt’s Ignite Proteomics SPAC Deal - Stocktwits
Aditxt Company Profile & Introduction - Moomoo
ADTX Stock Rockets 90% Premarket: What's Fueling Rebound After A Record 22-Day Selloff? - Stocktwits
Aditxt sells Pearsanta subsidiary, keeps up to $2.5M royalty upside - Dealroom
ADTX Stock Crashes Over 20% After Third Reverse Split In 7 Months – Retail Calls The Decline ‘Unreasonable’ - Stocktwits
Aditxt completes sale of Pearsanta subsidiary, retains up to $2.5M royalty stream - Minichart
Form 8K Aditx Therapeutics Inc For: 19 August By Investing.com - Investing.com South Africa
Aditxt sells majority-owned Pearsanta; retains royalties, milestone payments - TradingView
Aditxt (NASDAQ: ADTX) exits Pearsanta but keeps slice of future sales - Stock Titan
Aditxt Inc (ADTX) Performance - The Globe and Mail
Aditxt (ADTX) Quarter in Focus: The Company Releases Its Current Earnings Data in the Latest Session ; Share-Price Response Remains UnconfirmedAnalyst Consensus Shift - dars.gov.et
Aditxt (ADTX) Quarterly Performance Check: The Company Publishes Its Latest Results Reported Without a Verified Price ReactionEarnings Sentiment Score - vinanet.vn
An undisclosed buyer acquired 90.20% stake in Pearsanta, Inc. from Aditxt, Inc.. - marketscreener.com
Why Is ADTX Stock In Spotlight Today? - Stocktwits
ADTX Stock Loses Nasdaq Listing After Seven Reverse Splits Fail To Restore Compliance: Why Is Retail Still Bullish? - Stocktwits
MSN Money - MSN
Aditxt(ADTX) Stock Options Chain | Quotes & News - Moomoo
Aditxt amends note agreement, expands secured financing - The Globe and Mail
Aditxt Amends Note Purchase Pact to Add Investor, Swap Notes With No Change in Principal - TradingView
Aditxt (NASDAQ: ADTX) revises note deal, issues more secured notes - Stock Titan
Wey Ann Tai Net Worth (2026) - GuruFocus
ADTX Q3 2025 Earnings: Deep Losses Persist as Pre-Revenue Biotech Navigates Cash ConstraintsNon-GAAP Earnings - dars.gov.et
大文字化:
|
ボリューム (24 時間):